UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053392
Receipt number R000060901
Scientific Title Prediction of Postoperative Complications in Digestive Surgery with Cervical and Thoracic Operations: A Retrospective Study of the Improvement of POSSUM and E-PASS and Its Significance
Date of disclosure of the study information 2024/01/18
Last modified on 2024/01/18 19:45:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prediction of Postoperative Complications in Digestive Surgery with Cervical and Thoracic Operations: A Retrospective Study of the Improvement of POSSUM and E-PASS and Its Significance

Acronym

Prediction of Postoperative Complications in Digestive Surgery with Cervical and Thoracic Operations: A Retrospective Study of the Improvement of POSSUM and E-PASS and Its Significance

Scientific Title

Prediction of Postoperative Complications in Digestive Surgery with Cervical and Thoracic Operations: A Retrospective Study of the Improvement of POSSUM and E-PASS and Its Significance

Scientific Title:Acronym

Prediction of Postoperative Complications in Digestive Surgery with Cervical and Thoracic Operations: A Retrospective Study of the Improvement of POSSUM and E-PASS and Its Significance

Region

Japan


Condition

Condition

All diseases (including malignant tumors and benign diseases) that are subject to gastrointestinal surgery with neck and thoracic operations

Classification by specialty

Surgery in general Gastrointestinal surgery Hepato-biliary-pancreatic surgery
Vascular surgery Chest surgery Oto-rhino-laryngology
Cardiovascular surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We will retrospectively examine the usefulness of POSSUM (Physiological and Operative Severity Score for enUmeration of Mortality and morbidity) and E-PASS ( Estimation of Physiologic and Surgical Stress) as predictors of postoperative complications.

Basic objectives2

Others

Basic objectives -Others

Postoperative complications and other outcomes (length of hospital stay, prognosis) will be examined, and the by-products (impact on length of hospital stay and prognosis) of postoperative complication prediction and countermeasures will also be examined retrospectively.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Improvement in both prediction accuracy and usefulness of appropriate postoperative complication prediction formulas in gastrointestinal surgery with neck to chest manipulation through improvements in POSSUM and E-PASS.

Key secondary outcomes

By-products (impact on length of hospital stay and prognosis) resulting from postoperative complication prediction and countermeasures


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Gastrointestinal surgery under general anesthesia with cervical to thoracic manipulation after July 1, 2005 and before December 31, 2023.
2) Surgeries requiring gastrointestinal surgical support including cervical to thoracic manipulation, regardless of whether it is benign or malignant, are covered.
2) General anesthesia surgery cases.
3) The patient must be at least 18 years of age at the time of surgery.

Key exclusion criteria

1) Surgeries involving cervical to thoracic manipulation that can be completed in cardiovascular surgery, respiratory surgery, and otorhinolaryngology, regardless of gastrointestinal surgery, will be excluded.
2) Cases in which refusal to participate is communicated after disclosure of opt-out will be excluded.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Hikota
Middle name
Last name Hayashi

Organization

Faculty of Mediceine, Shimane University

Division name

Department of Digestive and General Surgery

Zip code

693-8501

Address

89-1 Enya-cho, Izumo City, Shimane Prefecture

TEL

0853-20-2232

Email

hikota@med.shimane-u.ac.jp


Public contact

Name of contact person

1st name Hikota
Middle name
Last name Hayashi

Organization

Faculty of Medicine, Shimane University

Division name

Department of Digestive and General Surgery

Zip code

683-8501

Address

89-1, Enya-cho, Izumo City, Shimane, Japan

TEL

0853-20-2232

Homepage URL


Email

hikota@med.shimane-u.ac.jp


Sponsor or person

Institute

Shimane University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Research Ethics Committee,Shimane University Faculty of Medicine

Address

89-1, Enya-cho, Izumo City, Shimane, Japan

Tel

0853-20-2515

Email

kenkyu@med.shimane-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 01 Month 12 Day

Date of IRB


Anticipated trial start date

2024 Year 01 Month 18 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

N/A


Management information

Registered date

2024 Year 01 Month 18 Day

Last modified on

2024 Year 01 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060901